Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year. It requires careful calculations of insulin needs and bothersome daily ...
MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...
The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...
Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...
In a retrospective study of the algorithm, McGill researchers used it to analyze blood sugar readings and insulin dosing data collected from 20 users of the Bigfoot Unity system, and found that the ...
Unexplained hyperglycemic episodes in patients with type 1 diabetes (T1D) who are using automated insulin delivery (AID) systems may be a sign of undetected occlusions, new data showed. In addition, ...
Findings of the review showed that continuous insulin infusion, coupled with standard oral lipid lowering therapies, successfully treated the hypertriglyceridemia. A case series published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results